Drug Product & Fill-Finish
Drug product is where the molecule becomes the medicine a patient actually receives. This pillar covers formulation and cryoformulation, fill-finish operations, lyophilization cycle development, container closure integrity, and the specific drug product challenges of RNAi-LNP, GalNAc conjugate, AAV gene therapy, and autologous cell therapy modalities.
- Beginner→Cold Chain for Advanced Therapies: Qualifying Cryoshippers and Dry-Vapor Shippers
How to qualify the cold chain for cell and gene therapies: shipper types, shipping study design, real-time monitoring and alert escalation, reverse logistics, customs and import contingency planning, and how a temperature excursion actually gets investigated.
- Intermediate→Filter Validation for Biologics and Oligonucleotides
How to build a sterilizing-grade filter validation package: bacterial retention studies with the manufacturer, product-specific versus matrix bracketing, the extractables handoff, routine integrity testing, and the traps that catch low-volume programs.
- Advanced→Building a Container Closure Integrity Program Under USP <1207>
How to build a CCIT program that holds up in an inspection: deterministic versus probabilistic methods, matching the method to vials, prefilled syringes, and cryobags, validating the method itself, and testing at the right points across the lifecycle.
- Advanced→Formulation Development Patterns Across Advanced Therapies
How formulation logic shifts from proteins to oligonucleotides to cells to AAV vectors: stability drivers, excipient choices, custom cryoformulation development, mixing equipment selection, lyophilization cycle basics, and what changes at high concentration heading toward a prefilled syringe.